Keeping cancer on the run: Polo Under the...
World-class polo, free cancer education seminar return to Sarasota
MD Anderson News Release 02/26/13
HOUSTON, TX —Polo Under the Palms rides into Sarasota, Fla. March 23. Proceeds from the third annual polo competition, silent auction and post-game soiree benefit cancer research at The University of Texas MD Anderson Cancer Center.
“As we’ve grown, so has the excitement,” says Jamie Uihlein of...
UT MD Anderson study shows new approach connecting smokers to quit...
Targeted intervention in health care settings may reduce tobacco-related illness and death
MD Anderson News Release 02...
Picture this: Imaging pioneer brings UT MD Anderson an innovative,...
Leader David Piwnica-Worms drawn by exciting vision, opportunities, resources
MD Anderson News Release 02/15/13
Versatile bench-to-bedside scientist,...
"Uniquely qualified to guide ...sciences into exciting era of vibrant discovery, clinical impact"
MD Anderson News Release 02/15/13
Helen Piwnica-Worms, Ph.D., a leader and scientist whose success in cancer research spans the spectrum from basic science discovery through arduous preclinical follow up and delivery of potential new drugs to clinical trial, will lead science research at The University of Texas MD...
Infographic: How to Make a Cancer-Fighting Snack
UT MD Anderson experts encourage adults to eat healthy foods every few hours
MD Anderson News Release 02/14/13
...
Protein central to cancer stem cell formation provides new...
Protein central to cancer stem cell formation provides new potential target
MD Anderson News Release 02/13/13
Researchers...
Deep genomic analysis identifies a micro RNA opponent for ovarian...
UT MD Anderson scientists find miR-506 works by blocking epithelial-to-mesenchymal cell transition
MD Anderson News Release...
Synthetic circuit allows dialing gene expression up or down in...
Ability to tune gene activity will permit refined research for drug resistance, cancer
MD Anderson News Release 02/11/...
Study drug is first to help patients with recurrent low-grade...
Clinical trial shows targeted therapy shrinks tumors; a step toward individualized treatment
MD Anderson News Release...